Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
4
×
cancer immunotherapy
4
×
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
astrazeneca
biogen
boston top stories
bristol-myers squibb
deals
eli lilly
fda
nonalcoholic steatohepatitis
alzheimer's disease
What
bio
roundup
4
×
drug
companies
nash
news
acquisitions
alzheimer’s
announced
annual
approval
approved
assessed
attention
biogen’s
biopharmaceutical
biotech
ceo
collabs
communities
conference
convo
covid
daniel
deal
digital
disease
earlier
epidemic
esmo
europe
failures
fatty
fda
frenzied
germany
gilead
gilead’s
growing
help
Language
unset
Current search:
roundup
×
cancer
×
abbvie
×
" cancer immunotherapy "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More